logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Keisuke Shigeta

keio university school of medicine
H指数:17
被引数:798

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “Profiling Fibroblast Growth Factor Receptor 3 Expression Based on the Immune Microenvironment in Upper Tract Urothelial Carcinoma” [European Urology Oncology 7(6) (2024) 1338–1349]

更正：“基于免疫微环境对上尿路尿路上皮癌中成纤维细胞生长因子受体3表达的分析”[欧洲泌尿肿瘤学 7(6) (2024) 1338–1349]

European Urology Oncology
IF9.3
2026-11-050
OA
Keisuke Shigeta; Kazuhiro Matsumoto; Sotaro Kitaoka; Minami Omura; Kota Umeda; Yuki Arita; Shuji Mikami; Keishiro Fukumoto; Yota Yasumizu; Nobuyuki Tanaka; Toshikazu Takeda; Shinya Morita; Takeo Kosaka; Ryuichi Mizuno; Satoshi Hara; Mototsugu Oya
M1C is a druggable target for NSCLC KRAS G12C mutant tumors resistant to KRAS inhibitors

M1C是耐药KRAS抑制剂的非小细胞肺癌KRAS G12C突变肿瘤的可成药靶点

Oncogene
IF7.3
2026-08-050
OA
Shinkichi Takamori; Naoki Haratake; Atrayee Bhattacharya; Hiroki Ozawa; Keisuke Shigeta; Mai Onishi; Kentaro Nonaka; Takefumi Komiya; Hiroki Komatsuda; Tomoyoshi Takenaka; Tomoharu Yoshizumi; Chendi Li; Jiehui Deng; Aaron N. Hata; Kwok K. Wong; Mark D. Long; Donald Kufe
MUCIN 1 confers inflammatory memory of tyrosine kinase inhibitor resistance in non-small cell lung cancer

黏蛋白1赋予非小细胞肺癌酪氨酸激酶抑制剂耐药的炎症记忆

Signal Transduction and Targeted Therapy
IF52.7
2025-11-280
OAAI
Shinkichi Takamori; Naoki Haratake; Atrayee Bhattacharya; Chie Kikutake; Hiroki Ozawa; Keisuke Shigeta; Ayako Nakashoji; Hideko Isozaki; Mototsugu Shimokawa; Mikita Suyama; Asato Hashinokuchi; Kazuki Takada; Gouji Toyokawa; Yuichi Yamada; Tomoyoshi Takenaka; Kenichi Taguchi; Masafumi Yamaguchi; Tomoharu Yoshizumi; Aaron N. Hata; Donald Kufe
MUC1-C auto-regulatory complex with EBNA1 is responsible for latent Epstein-Barr virus-associated gastric cancer progression

MUC1-C与EBNA1的自调控复合物负责潜伏性EB病毒相关胃癌的进展

Oncogene
IF7.3
2025-08-050
OA
Hiroki Ozawa; Yin Wang; Henry G. Withers; Naoki Haratake; Ayako Nakashoji; Atrayee Bhattacharya; Atsushi Fushimi; Chie Kikutake; Kazuhiro Yamanoi; Shaowen White; Keyi Wang; Tatsuaki Daimon; Keisuke Shigeta; Kazumasa Fukuda; Hirofumi Kawakubo; Yuko Kitagawa; Mark D. Long; Benjamin E. Gewurz; Donald Kufe
High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel Chemotherapy (vol 23, pg 4115, 2016)

高绝对单核细胞计数预测接受多西他赛化疗的去势抵抗性前列腺癌患者不良临床结局（vol 23, pg 4115, 2016）

ANNALS OF SURGICAL ONCOLOGY
IF3.5
2025-05-080
PRE
Shigeta, Keisuke; Kosaka, Takeo; Kitano, Shigehisa; Yasumizu, Yota; Miyazaki, Yasumasa; Mizuno, Ryuichi; Shinojima, Toshiaki; Kikuchi, Eiji; Miyajima, Akira; Tanoguchi, Hitoshi; Hasegawa, Shintaro; Oya, Mototsugu
Corrigendum to “Profiling FGFR3 Expression Based on the Immune Micro-environment in Upper Tract Urothelial Carcinoma” [Eur. Urol. Oncol. 7(6) (2024) 1338-1349]

勘误：“基于上尿路尿路上皮癌免疫微环境分析FGFR3表达特征”[Eur. Urol. Oncol. 7(6) (2024) 1338-1349]

European Urology Oncology
IF9.3
2025-05-060
OAAI
Keisuke Shigeta; Kazuhiro Matsumoto; Sotaro Kitaoka; Minami Omura; Kota Umeda; Yuki Arita; Shuji Mikami; Keishiro Fukumoto; Yota Yasumizu; Nobuyuki Tanaka; Toshikazu Takeda; Shinya Morita; Takeo Kosaka; Ryuichi Mizuno; Satoshi Hara; Mototsugu Oya
MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment

MUC1-C依赖性在药物耐药的HR+/HER2-乳腺癌中确定了一种新型抗体药物偶联物治疗靶点

NPJ BREAST CANCER
IF7.6
2025-04-260
OA
Nakashoji, Ayako; Bhattacharya, Atrayee; Ozawa, Hiroki; Haratake, Naoki; Shigeta, Keisuke; Fushimi, Atsushi; Yamashita, Nami; Matsui, Akira; Kure, Shoko; Kameyama, Tomoe; Takeuchi, Makoto; Fukuda, Kazumasa; Yokoe, Takamichi; Nagayama, Aiko; Hayahsida, Tetsu; Kitagawa, Yuko; Liu, Renyan; Giordano, Antonio; Jeselsohn, Rinath; Shapiro, Geoffrey I.; Kufe, Donald
Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology

膀胱影像报告和数据系统对不同组织学类型膀胱尿路上皮癌的诊断价值

EUROPEAN UROLOGY ONCOLOGY
IF9.3
2023-02-0111
OA
Arita, Yuki; Yoshida, Soichiro; Shigeta, Keisuke; Kwee, Thomas C.; Edo, Hiromi; Okawara, Naoko; Hashimoto, Masahiro; Ishii, Ryota; Ueda, Ryo; Mikami, Shuji; Fujiwara, Motohiro; Waseda, Yuma; Kikuchi, Eiji; Fujii, Yasuhisa; Jinzaki, Masahiro
Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer's Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy
EUROPEAN UROLOGY
IF25.2
2022-01-010
PRE
Shigeta, Keisuke; Matsumoto, Kazuhiro; Oya, Mototsugu

研究方向

暂未获取到该数据
M
Mototsugu Oya
H 指数:61论文数:1,162被引数:1.6万
E
Eiji Kikuchi
H 指数:56论文数:733被引数:1.5万
R
Ryuichi Mizuno
H 指数:34论文数:385被引数:6,243
A
Akira Miyajima
H 指数:43论文数:521被引数:6,651
T
Takeo Kosaka
H 指数:45论文数:717被引数:6,537
S
Shuji Mikami
H 指数:43论文数:365被引数:6,360
Y
Yuki Arita
H 指数:15论文数:68被引数:600
D
Donald Küfe
H 指数:123论文数:1,159被引数:5.0万
H
Hiroki Ozawa
H 指数:36论文数:317被引数:4,023
A
Atrayee Bhattacharya
H 指数:15论文数:128被引数:651